Keywords: b-ms, blenoxane, bristol-myers, squibb, supplemental, new, drug

B-MS' Blenoxane

Article | 04 March 1996

- Bristol-Myers Squibb's supplemental New Drug Application for Blenoxane (bleomycin sulfate) as a treatment for malignant pleural effusions has been approved ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Blenoxane

Bleomycin Sulfate Injection

Go to drug listing